Weighting:
ClosingPast Due
Unified Performance Management Blueprint - Phase 3
ID: 6534969-30
Potential Value
$2,030,666
Deal Value
$0
Stated Probability
50%
Days in Pipeline
203
Client & Account
Client
Onyx Pharmaceutical Innovations
Account
Titan Healthcare Systems
City
Boston
Region
USLI
Sub-Sector
SLED
Service Classification
Service Line
SaT
Field of Play
Strategy & Transformation
Opportunity Sub-SL
Strategy and Execution
Competency
S&E - Reimagine Reshape & Grow
Global Service Code
Disaster Recovery (42200)
People & Dates
Partner
Fischer Olivier
Pursuit Leader
Ross Diana
Open Date
Oct 22, 2025
Anticipated Win Date
Mar 31, 2026
Close Date
N/A
Details
Description
Unified Performance Management Blueprint - Phase 3
No win probability predictions available for this opportunity.